Affiliate (CLNN) files Form 144; Symbiosis II LLC lists multiple 2026 open‑market sales

Rhea-AI Filing Summary

CLNN filed a Form 144 notice reporting proposed sales of Common Stock, listing an entry of 401,891 shares under “Securities To Be Sold” (dated 09/30/2024) and multiple completed open-market sales by Symbiosis II LLC with trade dates and per-trade share counts and proceeds in 2026. The filing lists open-market purchase / resale activity and indicates cash transactions.

Insights

Securities Attorney

Form 144 lists proposed and recent resale transactions by an affiliate, preserving disclosure requirements.

Section 144 notices are procedural disclosures required when an affiliate intends to sell restricted or control securities in reliance on Rule 144. This filing lists a reported 401,891 shares quantity under “Securities To Be Sold” and numerous executed open-market trades by Symbiosis II LLC in 2026.

The filing does not state limiting conditions such as a beneficial ownership cap or whether the sales are subject to any lock-up; cash-flow treatment for the issuer is described as Cash for listed trades. Subsequent public filings or trade reports would show actual market impact.

Key Figures

Securities to be sold: 401,891 shares Trade example: 19,621 shares Largest listed trade example: 67,991 shares +1 more

4 metrics

Securities to be sold 401,891 shares listed under “Securities To Be Sold” dated <date>09/30/2024</date>

Trade example 19,621 shares trade dated <date>01/14/2026</date> with proceeds <money>$100,496.05</money>

Largest listed trade example 67,991 shares trade dated <date>03/31/2026</date> with proceeds <money>$332,103.67</money>

Example trade proceeds <money>$119,855.20</money> proceeds from 24,925-share trade dated <date>04/02/2026</date>

Key Terms

Open Market Purchase, Issuer, Cash

3 terms

Open Market Purchase market

"Securities To Be Sold row shows "Open Market Purchase" (max 100 chars)"

An open market purchase is when a company buys its own shares on public stock exchanges the same way any investor would, rather than through a private deal. Investors care because these purchases reduce the number of shares available, can boost earnings per share and share price, signal that management thinks the stock is undervalued, and use company cash that might otherwise go to reinvestment or dividends — like a business quietly buying back its own tickets at the box office.

Issuer regulatory

"Securities To Be Sold row includes the word "Issuer" (max 100 chars)"

Cash market

"Trade rows list consideration as "Cash" for each sale (max 100 chars)"

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Merrill Lynch 555 California St Ste 1800 San Francisco CA 94104	104825	669831.75	11778307	04/15/2026	Nasdaq

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	09/30/2024	Open Market Purchase	Issuer			401891	09/30/2024	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Symbiosis II LLC 609 SW 8th St Ste 510 Bentonville AR 72712	Common	01/14/2026	19621	100496.05
Symbiosis II LLC 609 SW 8th St Ste 510 Bentonville AR 72712	Common	01/15/2026	12563	64040.34
Symbiosis II LLC 609 SW 8th St Ste 510 Bentonville AR 72712	Common	01/16/2026	7923	40626.13
Symbiosis II LLC 609 SW 8th St Ste 510 Bentonville AR 72712	Common	01/20/2026	12432	59731.78
Symbiosis II LLC 609 SW 8th St Ste 510 Bentonville AR 72712	Common	01/21/2026	12119	61227.75
Symbiosis II LLC 609 SW 8th St Ste 510 Bentonville AR 72712	Common	01/22/2026	12665	67323.13
Symbiosis II LLC 609 SW 8th St Ste 510 Bentonville AR 72712	Common	01/23/2026	5556	29256.91
Symbiosis II LLC 609 SW 8th St Ste 510 Bentonville AR 72712	Common	01/26/2026	6418	32186.97
Symbiosis II LLC 609 SW 8th St Ste 510 Bentonville AR 72712	Common	01/27/2026	4139	21016.06
Symbiosis II LLC 609 SW 8th St Ste 510 Bentonville AR 72712	Common	01/28/2026	8717	42789.36
Symbiosis II LLC 609 SW 8th St Ste 510 Bentonville AR 72712	Common	01/29/2026	3810	15843.2
Symbiosis II LLC 609 SW 8th St Ste 510 Bentonville AR 72712	Common	01/29/2026	11474	50113.36
Symbiosis II LLC 609 SW 8th St Ste 510 Bentonville AR 72712	Common	01/30/2026	5686	23493.07
Symbiosis II LLC 609 SW 8th St Ste 510 Bentonville AR 72712	Common	02/02/2026	2050	8262.02
Symbiosis II LLC 609 SW 8th St Ste 510 Bentonville AR 72712	Common	02/02/2026	1750	7102.19
Symbiosis II LLC 609 SW 8th St Ste 510 Bentonville AR 72712	Common	02/03/2026	5559	22818.28
Symbiosis II LLC 609 SW 8th St Ste 510 Bentonville AR 72712	Common	03/24/2026	5492	31722.97
Symbiosis II LLC 609 SW 8th St Ste 510 Bentonville AR 72712	Common	03/25/2026	7098	39045.14
Symbiosis II LLC 609 SW 8th St Ste 510 Bentonville AR 72712	Common	03/26/2026	5319	28705.91
Symbiosis II LLC 609 SW 8th St Ste 510 Bentonville AR 72712	Common	03/27/2026	17470	82908.17
Symbiosis II LLC 609 SW 8th St Ste 510 Bentonville AR 72712	Common	03/30/2026	15536	79283.66
Symbiosis II LLC 609 SW 8th St Ste 510 Bentonville AR 72712	Common	03/31/2026	67991	332103.67
Symbiosis II LLC 609 SW 8th St Ste 510 Bentonville AR 72712	Common	04/01/2026	4278	21254.31
Symbiosis II LLC 609 SW 8th St Ste 510 Bentonville AR 72712	Common	04/02/2026	24925	119855.2

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does CLNN's Form 144 report show?

It reports proposed and recent affiliate sales of Common Stock. The filing lists 401,891 shares under “Securities To Be Sold” and multiple dated open-market trades by Symbiosis II LLC with share counts and proceeds in 2026.

Who conducted the recent sales listed in the filing?

The filing lists sales by Symbiosis II LLC. Individual trade rows show dates such as 01/14/2026 and per-trade share counts with dollar proceeds for each transaction.

Are the listed transactions open-market or private?

The filing identifies the trades as Open Market Purchase / resale activity. The securities rows indicate method as Open Market Purchase and list Cash as the transaction consideration for the trade entries.

Does the Form 144 state proceeds go to the issuer?

The trade rows label the transactions as Cash, but the filing lists the sales as resale/open-market by an affiliate. It does not state that proceeds are paid to the issuer in the provided excerpt.